87 results on '"Ezzedine, Khaled"'
Search Results
2. Estimating the burden of vitiligo: a systematic review and modelling study
3. Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1
4. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults
5. Improvements in Immune/Melanocyte Biomarkers With JAK3/TEC Family Kinase Inhibitor Ritlecitinib in Vitiligo
6. Economic Burden Among Patients with Vitiligo in the United States: A Retrospective Database Claims Study
7. Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis
8. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial
9. Sun Exposure and Protection Habits: Self-Reported Attitudes, Knowledge, and Behaviors
10. Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo
11. 34631 Do patients with vitiligo and health care professionals treating them recognize the burden in living with the disease in the United States? Findings from the VALIANT study
12. 34789 Efficacy and safety of ruxolitinib cream for the treatment of vitiligo: Week 24 pooled analysis of the TRuE-V phase 3 studies
13. 34612 Exploring the natural history of vitiligo in the United States: Findings from the VALIANT study
14. 35187 Efficacy and safety of ruxolitinib cream for the treatment of vitiligo by patient demographics and baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
15. Factors associated with perceived stress in patients with vitiligo in the ComPaRe e-cohort
16. Importance de la protection anti-UVA dans les écrans solaires
17. Les versions arabes du score d’activité de l’urticaire et le questionnaire sur la qualité de vie de l’urticaire chronique : validation et corrélation
18. Sentiments de culpabilité chez les parents d’enfants atteints de dermatite atopique
19. SkinPartner : un questionnaire pour évaluer l’impact d’une maladie de peau chez le conjoint
20. Perception de la sévérité clinique de la dermatite atopique chez l’enfant : comparaison entre l’évaluation des patients et celle des parents
21. La vie du partenaire est-elle affectée par la dermatite atopique de son conjoint ?
22. Évaluation de l’urticaire à l’aide d’un outil de diagnostic autodéclaré (SRUD) : une étude de validation multicentrique
23. Qualité de vie chez les adultes atteints de neurofibromatose de type 1 : développement et validation d’un nouvel outil de mesure
24. Supporte-t-on mieux sa dermatite atopique quand on vit en couple ?
25. Tacrolimus 0,1 % dans le vitiligo : pour une mise en conformité entre données de la science et prescription réglementaire
26. Angiomes rubis, une nouvelle caractéristique de neurofibromatose de type 1 : étude pilote
27. Beyond quality of life: A call for patients' own willingness to pay in chronic skin disease to assess psychosocial burden—A multicenter, cross-sectional, prospective survey
28. Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study
29. Perceived clinical severity of atopic dermatitis in adolescents: Comparison between patients' and parents' evaluation
30. Development of the PREDS Score to Predict In-Hospital Mortality of Patients With Ebola Virus Disease Under Advanced Supportive Care: Results From the EVISTA Cohort in the Democratic Republic of the Congo
31. 16983 Quality of life in patients with vitiligo: Results from a global patient survey
32. 17755 Global survey investigating the prevalence of vitiligo and vitiligo signs among adults in Europe, Japan, and the United States
33. Vitiligo: Targeted Therapies Add Color to Disease Pathophysiology
34. Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs)
35. Navigating the landscape of core outcome set development in dermatology
36. Building a scale for measuring burden of hand eczema: BoHEM
37. The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo
38. Validation study of the Vitiligo Extent Score-plus
39. Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
40. New discoveries in the pathogenesis and classification of vitiligo
41. Current and emerging treatments for vitiligo
42. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients
43. Development and validation of a patient-reported outcome measure in vitiligo: The Self Assessment Vitiligo Extent Score (SA-VES)
44. Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field
45. Rôle des lymphocytes T effecteurs mémoires CD4+ et CD8+ CXCR3+ dans la perte du mélanocyte au cours du vitiligo
46. Portable home phototherapy for vitiligo
47. Follicular vitiligo: A report of 8 cases
48. Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative
49. Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk
50. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.